18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is currently the standard technique to define minimal residual disease (MRD) status outside the bone marrow (BM) in patients with multiple myeloma (MM). This study aimed to define criteria for PET complete metabolic response after therapy, jointly analyzing a subgroup of newly diagnosed transplantation-eligible patients with MM enrolled in two independent European randomized phase III trials (IFM/DFCI2009 and EMN02/HO95).
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
Chauvie, Stephane;Boccadoro, Mario;Gay, Francesca;
2021-01-01
Abstract
18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is currently the standard technique to define minimal residual disease (MRD) status outside the bone marrow (BM) in patients with multiple myeloma (MM). This study aimed to define criteria for PET complete metabolic response after therapy, jointly analyzing a subgroup of newly diagnosed transplantation-eligible patients with MM enrolled in two independent European randomized phase III trials (IFM/DFCI2009 and EMN02/HO95).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
[PUBLISHED Vsn] Standardization of 18F-FDG-Pet-Ct according deauville criteria for metabolic.pdf
Accesso riservato
Descrizione: [PUBLISHED Vsn.] Zamagni et al. JCO 2021 - 10.1200/JCO.20.00386
Tipo di file:
PDF EDITORIALE
Dimensione
357.61 kB
Formato
Adobe PDF
|
357.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
